Johnson & Johnson   4Q Revenues: $17.6 billion (+8%) 4Q Earnings: $2.6 billion (earnings were $218 million in 4Q12) YTD Revenues: $67.2 billion (+3%) YTD Earnings: $10.5 billion (+9%) Comments: Pharmaceutical sales were $6.5 billion in the quarter, up 7%, and $25.4 billion for the year, up 4%. Remicade sales were $1.5 billion in the quarter, up 5% and $6.1 billion for the year, up 12%. Simponi sales were up 52% to $181 million in the quarter, and up 48% to $607 million for the year. Stel...